The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden - the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study

被引:58
|
作者
Danielsson, Patrik
Olafsdottir, Inga Sif [1 ]
Benediktsdottir, Bryndis [2 ]
Gislason, Thorarinn [2 ]
Janson, Christer
机构
[1] Uppsala Univ, Akad Univ Hosp, Dept Med Sci Resp Med & Allergol, SE-75185 Uppsala, Sweden
[2] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland
来源
CLINICAL RESPIRATORY JOURNAL | 2012年 / 6卷 / 02期
关键词
chronic obstructive pulmonary disease; c-reactive protein; forced expiratory volume in 1 second; forced vital capacity; interleukin-6; tuberculosis; AIR-FLOW OBSTRUCTION; QUALITY-OF-LIFE; RISK-FACTORS; COPD; DIAGNOSIS; CRITERIA; GOLD; TUBERCULOSIS; SYMPTOMS; SMOKING;
D O I
10.1111/j.1752-699X.2011.00257.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objectives: To estimate chronic obstructive pulmonary disease (COPD) prevalence in Uppsala and the impact of risk factors on disease prevalence using the standardised methods of the Burden of Obstructive Lung Disease (BOLD) study initiative. Methods: Randomly selected participants, aged 40 years or more (n = 548) responded to a questionnaire regarding smoking habits, respiratory symptoms, medical history, and exposure to airway irritants. Spirometry, with a post-bronchodilator test, was performed and COPD defined as post-bronchodilatory forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) < 0.70 or FEV1/FVC < lower limit of normality (LLN). Circulatory inflammatory markers were measured. Results: COPD prevalence was 16.2%, which was the fourth lowest prevalence of COPD, compared with 12 other BOLD centres. Main risk factors for COPD were increasing age [odds ratio (OR) = 2.08 per 10 years] and smoking (OR = 1.33 per 10 pack years). Higher education was protective (OR = 0.70 per 5 years). Previous tuberculosis was an almost significant risk factor for COPD (P = 0.08). Subjects with COPD reported more respiratory symptoms but only 29% had previous doctor diagnosed COPD, asthma, chronic bronchitis or emphysema. Participants with COPD had higher levels of C-reactive protein (P = 0.01), but no difference was observed in interleukin 6 (IL-6) levels. Using LLN instead of the fixed FEV1/FVC ratio reduced the prevalence of COPD to 10%. Conclusion: COPD prevalence in Uppsala was similar to other BOLD centres in high-income countries. Apart from known COPD risk factors (age, smoking, lower educational level), a history of tuberculosis may be associated with COPD even in high-income countries. COPD remains under-diagnosed, as only 29% of subjects with COPD had a previously diagnosed lung disorder.
引用
收藏
页码:120 / 127
页数:8
相关论文
共 50 条
  • [41] Prevalence and clinical impact of anemia in patients diagnosed with chronic obstructive pulmonary disease: A cross-sectional study
    Rimal, Suman
    Das, Santa K.
    Basnet, Anita
    Rauniyar, Tej P.
    Pandey, Kundan Raj
    Kuikel, Sandip
    [J]. HEALTH SCIENCE REPORTS, 2023, 6 (06)
  • [42] Prevalence and Severity of Chronic Obstructive Pulmonary Disease in People with Type 2 Diabetes: A Cross-Sectional Study
    Bera, Mridul
    Gupta, Amit
    Ahmed, Rishad
    Baidya, Arjun
    Guha, Mrinal Kanti
    [J]. CLINICAL DIABETOLOGY, 2023, 12 (05): : 308 - 314
  • [43] Obstructive sleep apnea, chronic obstructive pulmonary disease and hypertensive microvascular disease: a cross-sectional observational cohort study
    Sky Chew
    Deb Colville
    Anastasia Hutchinson
    Piers Canty
    Lauren Hodgson
    Judy Savige
    [J]. Scientific Reports, 12
  • [44] Obstructive sleep apnea, chronic obstructive pulmonary disease and hypertensive microvascular disease: a cross-sectional observational cohort study
    Chew, Sky
    Colville, Deb
    Hutchinson, Anastasia
    Canty, Piers
    Hodgson, Lauren
    Savige, Judy
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [45] Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study
    Koo, Hyun-Kyoung
    Vasilescu, Dragos M.
    Booth, Steven
    Hsieh, Aileen
    Katsamenis, Orestis L.
    Fishbane, Nick
    Elliott, W. Mark
    Kirby, Miranda
    Lackie, Peter
    Sinclair, Ian
    Warner, Jane A.
    Cooper, Joel D.
    Coxson, Harvey O.
    Pare, Peter D.
    Hogg, James C.
    Hackett, Tillie-Louise
    [J]. LANCET RESPIRATORY MEDICINE, 2018, 6 (08): : 591 - 602
  • [46] Prevalence of Chronic Obstructive Pulmonary Disease (COPD) from 1996 to 2006: A Population-Based Study
    Gershon, A. S.
    Wang, C.
    Wilton, A. S.
    To, T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [47] The prevalence of chronic obstructive pulmonary disease (COPD) in Germany: results of the BOLD Study
    Geldmacher, H.
    Biller, H.
    Herbst, A.
    Urbanski, K.
    Allison, M.
    Buist, A. S.
    Hohlfeld, J. M.
    Welte, T.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (50) : 2609 - 2614
  • [48] The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study
    Al Ghobain, M.
    Alhamad, E. H.
    Alorainy, H. S.
    Al Kassimi, F.
    Lababidi, H.
    Al-Hajjaj, M. S.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (10) : 1252 - 1257
  • [49] Characteristics of asthma chronic obstructive pulmonary disease overlap among chronic obstructive pulmonary disease and asthma patients: Based on one center cross-sectional study
    Turan, Onur
    Polat, Fatos
    Kara, Ayse Gizem Eren
    Sozmen, Kaan
    [J]. EURASIAN JOURNAL OF PULMONOLOGY, 2021, 23 (02) : 122 - 127
  • [50] Dyspnoea in the multinational Burden of Obstructive Lung Disease (BOLD) study
    Mueller, A.
    Wouters, E. F.
    Hartl, S.
    Janssen, D. J.
    Amaral, A. F.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 564 - 564